Treatment of ascites: Part I. Pharmacological armamentarium

Orsolya Halmos, Paolo Inturri, Lorenzo Rossaro

Research output: Contribution to journalArticle

Abstract

Ascites is a frequent complication of cirrhosis and results from increased sodium and water retention with fluid accumulation in the peritoneal cavity. This complication not only impairs the quality of life of patients with advanced liver disease, but also represents an important cost to society. The main therapeutic goal is to achieve negative sodium balance by sodium restriction and diuretics. Aldosterone antagonists are the first- line treatment and 50-90% of patients respond to these drugs alone. Loop diuretics are effectively combined with aldosterone antagonists with an additional increase in the response rate to 90%. Side effect profiles for both classes of drugs are acceptable but need to be recognized (electrolyte disturbance, renal impairment, gynecomastia). Other possible effective drugs under investigation are torasemide, atrial natriuretic factor, vasopressin and aquaretics. In the case of refractory or tense ascites, paracentesis is the first choice of treatment, while alternative procedures such as peritoneovenous shunts, transjugular intrahepatic portosystemic stent shunt and liver transplantation should be considered in patients whose ascites reaccumulates despite intensive conservative therapy.

Original languageEnglish (US)
Pages (from-to)343-352
Number of pages10
JournalDrugs of Today
Volume33
Issue number5
StatePublished - 1997
Externally publishedYes

Fingerprint

Ascites
Mineralocorticoid Receptor Antagonists
torsemide
Sodium
Pharmacology
Peritoneovenous Shunt
Pharmaceutical Preparations
Transjugular Intrahepatic Portasystemic Shunt
Sodium Potassium Chloride Symporter Inhibitors
Gynecomastia
Paracentesis
Peritoneal Cavity
Atrial Natriuretic Factor
Vasopressins
Diuretics
Liver Transplantation
Electrolytes
Stents
Liver Diseases
Fibrosis

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Treatment of ascites : Part I. Pharmacological armamentarium. / Halmos, Orsolya; Inturri, Paolo; Rossaro, Lorenzo.

In: Drugs of Today, Vol. 33, No. 5, 1997, p. 343-352.

Research output: Contribution to journalArticle

Halmos, O, Inturri, P & Rossaro, L 1997, 'Treatment of ascites: Part I. Pharmacological armamentarium', Drugs of Today, vol. 33, no. 5, pp. 343-352.
Halmos, Orsolya ; Inturri, Paolo ; Rossaro, Lorenzo. / Treatment of ascites : Part I. Pharmacological armamentarium. In: Drugs of Today. 1997 ; Vol. 33, No. 5. pp. 343-352.
@article{8cde0af7b81e414fb163d87dca7cf9b4,
title = "Treatment of ascites: Part I. Pharmacological armamentarium",
abstract = "Ascites is a frequent complication of cirrhosis and results from increased sodium and water retention with fluid accumulation in the peritoneal cavity. This complication not only impairs the quality of life of patients with advanced liver disease, but also represents an important cost to society. The main therapeutic goal is to achieve negative sodium balance by sodium restriction and diuretics. Aldosterone antagonists are the first- line treatment and 50-90{\%} of patients respond to these drugs alone. Loop diuretics are effectively combined with aldosterone antagonists with an additional increase in the response rate to 90{\%}. Side effect profiles for both classes of drugs are acceptable but need to be recognized (electrolyte disturbance, renal impairment, gynecomastia). Other possible effective drugs under investigation are torasemide, atrial natriuretic factor, vasopressin and aquaretics. In the case of refractory or tense ascites, paracentesis is the first choice of treatment, while alternative procedures such as peritoneovenous shunts, transjugular intrahepatic portosystemic stent shunt and liver transplantation should be considered in patients whose ascites reaccumulates despite intensive conservative therapy.",
author = "Orsolya Halmos and Paolo Inturri and Lorenzo Rossaro",
year = "1997",
language = "English (US)",
volume = "33",
pages = "343--352",
journal = "Drugs of Today",
issn = "1699-3993",
publisher = "Prous Science",
number = "5",

}

TY - JOUR

T1 - Treatment of ascites

T2 - Part I. Pharmacological armamentarium

AU - Halmos, Orsolya

AU - Inturri, Paolo

AU - Rossaro, Lorenzo

PY - 1997

Y1 - 1997

N2 - Ascites is a frequent complication of cirrhosis and results from increased sodium and water retention with fluid accumulation in the peritoneal cavity. This complication not only impairs the quality of life of patients with advanced liver disease, but also represents an important cost to society. The main therapeutic goal is to achieve negative sodium balance by sodium restriction and diuretics. Aldosterone antagonists are the first- line treatment and 50-90% of patients respond to these drugs alone. Loop diuretics are effectively combined with aldosterone antagonists with an additional increase in the response rate to 90%. Side effect profiles for both classes of drugs are acceptable but need to be recognized (electrolyte disturbance, renal impairment, gynecomastia). Other possible effective drugs under investigation are torasemide, atrial natriuretic factor, vasopressin and aquaretics. In the case of refractory or tense ascites, paracentesis is the first choice of treatment, while alternative procedures such as peritoneovenous shunts, transjugular intrahepatic portosystemic stent shunt and liver transplantation should be considered in patients whose ascites reaccumulates despite intensive conservative therapy.

AB - Ascites is a frequent complication of cirrhosis and results from increased sodium and water retention with fluid accumulation in the peritoneal cavity. This complication not only impairs the quality of life of patients with advanced liver disease, but also represents an important cost to society. The main therapeutic goal is to achieve negative sodium balance by sodium restriction and diuretics. Aldosterone antagonists are the first- line treatment and 50-90% of patients respond to these drugs alone. Loop diuretics are effectively combined with aldosterone antagonists with an additional increase in the response rate to 90%. Side effect profiles for both classes of drugs are acceptable but need to be recognized (electrolyte disturbance, renal impairment, gynecomastia). Other possible effective drugs under investigation are torasemide, atrial natriuretic factor, vasopressin and aquaretics. In the case of refractory or tense ascites, paracentesis is the first choice of treatment, while alternative procedures such as peritoneovenous shunts, transjugular intrahepatic portosystemic stent shunt and liver transplantation should be considered in patients whose ascites reaccumulates despite intensive conservative therapy.

UR - http://www.scopus.com/inward/record.url?scp=0030740797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030740797&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030740797

VL - 33

SP - 343

EP - 352

JO - Drugs of Today

JF - Drugs of Today

SN - 1699-3993

IS - 5

ER -